Stay updated on CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma

Sign up to get notified when there's something new on the CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma page.
Latest website image capture
Clouds background image

Latest updates to the CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    0.5%
    Check dated 2026-10-21T01:11:35.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-07T01:18:11.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 has been added to the record history, and the previous revision v3.6.6 has been removed.
    Difference
    0.1%
    Check dated 2026-09-16T00:31:25.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The header of the Record History page now shows Revision: v3.6.6, replacing the previous v3.6.5. This reflects a minor frontend/backend update to the history view without altering the underlying study information.
    Difference
    0.1%
    Check dated 2026-09-01T20:30:08.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 appears in the study's history with a Study Status update. This indicates the record has been revised and the trial's status has been updated within the official history.
    Difference
    0.3%
    Check dated 2026-08-11T17:56:44.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The record history shows a new revision label (v3.6.4) replacing the previous v3.6.3, indicating a small update to the page framework without impacting trial details.
    Difference
    0.1%
    Check dated 2026-07-21T12:52:46.000Z thumbnail image

Stay in the know with updates to CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma

Enter your email address, and we'll notify you when there's something new on the CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma page.